Afuco™ Anti-IL17RA ADCC Therapeutic Antibody (Ixekizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL17RA. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-217 |
| Pricing | Inquiry |
| Host | Human |
| Target | IL17RA |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, FC, IP, FuncS, IF |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |